Ab­b­Vie of­floads UK site for $119M in sale to Chi­nese cell and gene ther­a­py play­er Phar­maron

With its Al­ler­gan buy­out now long in the books, Ab­b­Vie has been tak­ing a hard look at its sud­den­ly ex­pan­sive glob­al ops to find space for a deal. Now, work­ing with a Chi­nese cell and gene ther­a­py play­er hun­gry for more el­bow room abroad, Ab­b­Vie has tak­en one UK fa­cil­i­ty off its books.

Ab­b­Vie has of­floaded its Liv­er­pool man­u­fac­tur­ing site as part of a $118.7 mil­lion sale to Chi­nese cell and gene ther­a­py play­er Phar­maron, which is pitch­ing the pur­chase as the next step in its glob­al ex­pan­sion plans, the com­pa­nies said last week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER